With an aim at discovering novel actionable targets in PTEN-deficient CRC, we performed synthetic lethality drug screens against a highly selective compound library comprising 318 highly-specific small molecule inhibitors of various human druggable targets and identified several potential synthetic lethal candidates, including MDM2 inhibitors 12. The gene discussed is PTEN; the disease is colorectal carcinoma.